Found: 14
Select item for more details and to access through your institution.
Prophylactic negative pressure wound therapy following colorectal perforation: defining the risk factors for delayed wound healing.
- Published in:
- Surgery Today, 2023, v. 53, n. 6, p. 728, doi. 10.1007/s00595-022-02631-3
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 4, p. 522, doi. 10.1002/jcph.1050
- By:
- Publication type:
- Article
Vascular Hamartoma in the Uterus of a Female Sprague-Dawley Rat with an Episode of Vaginal Bleeding.
- Published in:
- Toxicologic Pathology, 2013, v. 41, n. 7, p. 1011, doi. 10.1177/0192623313476575
- By:
- Publication type:
- Article
Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Experimental study on arranging music by chaotic neural network.
- Published in:
- International Journal of Intelligent Systems, 1997, v. 12, n. 4, p. 323, doi. 10.1002/(SICI)1098-111X(199704)12:4<323::AID-INT5>3.0.CO;2-Q
- By:
- Publication type:
- Article
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 3, p. 314, doi. 10.1007/s12185-024-03822-z
- By:
- Publication type:
- Article
A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 1, p. 105, doi. 10.1007/s00280-021-04369-0
- By:
- Publication type:
- Article
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 105, doi. 10.1002/jha2.854
- By:
- Publication type:
- Article
Dose-dependent acceleration in the delayed effects of neonatal oral exposure to low-dose 17α-ethynylestradiol on reproductive functions in female Sprague-Dawley rats.
- Published in:
- Journal of Toxicological Sciences, 2015, v. 40, n. 6, p. 727, doi. 10.2131/jts.40.727
- By:
- Publication type:
- Article
Delayed effects of single neonatal subcutaneous exposure of low-dose 17α-ethynylestradiol on reproductive function in female rats.
- Published in:
- Journal of Toxicological Sciences, 2012, v. 37, n. 4, p. 681, doi. 10.2131/jts.37.681
- By:
- Publication type:
- Article
Impact of Red Blood Cell Transfusions on Quality of Life for Patients With Myelofibrosis in the SIMPLIFY-1 and SIMPLIFY-2 Clinical Trials.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 357
- By:
- Publication type:
- Article
Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) (MOMENTUM).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 388
- By:
- Publication type:
- Article
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 377
- By:
- Publication type:
- Article
Ultra-High Density Single Nanometer-Scale Anodic Alumina Nanofibers Fabricated by Pyrophosphoric Acid Anodizing.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep07411
- By:
- Publication type:
- Article